These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27198032)

  • 1. Draft Genome Sequence of Flavobacterium sp. Strain TAB 87, Able To Inhibit the Growth of Cystic Fibrosis Bacterial Pathogens Belonging to the Burkholderia cepacia Complex.
    Presta L; Inzucchi I; Bosi E; Fondi M; Perrin E; Miceli E; Tutino ML; Lo Giudice A; de Pascale D; Fani R
    Genome Announc; 2016 May; 4(3):. PubMed ID: 27198032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.
    Fondi M; Orlandini V; Maida I; Perrin E; Papaleo MC; Emiliani G; de Pascale D; Parrilli E; Tutino ML; Michaud L; Lo Giudice A; Fani R
    J Bacteriol; 2012 Nov; 194(22):6334-5. PubMed ID: 23105071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Draft Genome Sequences of the Antimicrobial Producers Pseudomonas sp. TAA207 and Pseudomonas sp. TAD18 Isolated from Antarctic Sediments.
    Presta L; Inzucchi I; Bosi E; Fondi M; Perrin E; Maida I; Miceli E; Tutino ML; Lo Giudice A; de Pascale D; Fani R
    Genome Announc; 2016 Jul; 4(4):. PubMed ID: 27469957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Draft genomes of three Antarctic Psychrobacter strains producing antimicrobial compounds against Burkholderia cepacia complex, opportunistic human pathogens.
    Fondi M; Orlandini V; Perrin E; Maida I; Bosi E; Papaleo MC; Michaud L; Lo Giudice A; de Pascale D; Tutino ML; Liò P; Fani R
    Mar Genomics; 2014 Feb; 13():37-8. PubMed ID: 24401162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Draft Genome Sequence of
    Maggini V; Presta L; Miceli E; Fondi M; Bosi E; Chiellini C; Fagorzi C; Bogani P; Di Pilato V; Rossolini GM; Mengoni A; Firenzuoli F; Perrin E; Fani R
    Genome Announc; 2017 May; 5(20):. PubMed ID: 28522712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.
    Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R
    Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome analysis of a new biosurfactants source: The Antarctic bacterium Psychrobacter sp. TAE2020.
    Riccardi C; D'Angelo C; Calvanese M; Ricciardelli A; Tutino ML; Parrilli E; Fondi M
    Mar Genomics; 2022 Feb; 61():100922. PubMed ID: 35058036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive volatile organic compounds from Antarctic (sponges) bacteria.
    Papaleo MC; Romoli R; Bartolucci G; Maida I; Perrin E; Fondi M; Orlandini V; Mengoni A; Emiliani G; Tutino ML; Parrilli E; de Pascale D; Michaud L; Lo Giudice A; Fani R
    N Biotechnol; 2013 Sep; 30(6):824-38. PubMed ID: 23619351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of three sponge-associated Arthrobacter Antarctic strains, inhibiting the growth of Burkholderia cepacia complex bacteria by synthesizing volatile organic compounds.
    Orlandini V; Maida I; Fondi M; Perrin E; Papaleo MC; Bosi E; de Pascale D; Tutino ML; Michaud L; Lo Giudice A; Fani R
    Microbiol Res; 2014; 169(7-8):593-601. PubMed ID: 24231161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
    Coenye T; Mahenthiralingam E; Henry D; LiPuma JJ; Laevens S; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Jul; 51(Pt 4):1481-1490. PubMed ID: 11491349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft Genome Sequence of
    Teoh CP; Lavin P; Najimudin N; Lee PC; Iancu L; Purcarea C; Wong CMVL
    Microbiol Resour Announc; 2021 Feb; 10(8):. PubMed ID: 33632855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients.
    Bloodworth RA; Selin C; López De Volder MA; Drevinek P; Galanternik L; Degrossi J; Cardona ST
    Genome Announc; 2015 Aug; 3(4):. PubMed ID: 26251482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia puraquae sp. nov., a novel species of the Burkholderia cepacia complex isolated from hospital settings and agricultural soils.
    Martina P; Leguizamon M; Prieto CI; Sousa SA; Montanaro P; Draghi WO; Stämmler M; Bettiol M; de Carvalho CCCR; Palau J; Figoli C; Alvarez F; Benetti S; Lejona S; Vescina C; Ferreras J; Lasch P; Lagares A; Zorreguieta A; Leitão JH; Yantorno OM; Bosch A
    Int J Syst Evol Microbiol; 2018 Jan; 68(1):14-20. PubMed ID: 29095137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Draft Genome Sequence of Pseudomonas sp. EpS/L25, Isolated from the Medicinal Plant Echinacea purpurea and Able To Synthesize Antimicrobial Compounds.
    Presta L; Bosi E; Fondi M; Maida I; Perrin E; Miceli E; Maggini V; Bogani P; Firenzuoli F; Di Pilato V; Rossolini GM; Mengoni A; Fani R
    Genome Announc; 2016 May; 4(3):. PubMed ID: 27151804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavobacterium frigidimaris sp. nov., isolated from Antarctic seawater.
    Nogi Y; Soda K; Oikawa T
    Syst Appl Microbiol; 2005 Jun; 28(4):310-5. PubMed ID: 15997703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.
    Chiellini C; Maida I; Maggini V; Bosi E; Mocali S; Emiliani G; Perrin E; Firenzuoli F; Mengoni A; Fani R
    Microbiol Res; 2017 Mar; 196():34-43. PubMed ID: 28164789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Genome Sequence of Burkholderia cepacia Strain LO6.
    Belcaid M; Kang Y; Tuanyok A; Hoang TT
    Genome Announc; 2015 Jun; 3(3):. PubMed ID: 26067955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.